Change search
ReferencesLink to record
Permanent link

Direct link
Overall survival (OS) in metastatic renal cell carcinoma (MRCC): a comparison between sorafenib (SO) and best supportive care (BSC)after first line treatment with sunitinib (SU) inSweden
Show others and affiliations
2012 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 23, no Suppl. 9, 281-281 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Oxford University Press, 2012. Vol. 23, no Suppl. 9, 281-281 p.
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-61572ISI: 000309409001330OAI: diva2:582094
37th Congress of the European-Society-for-Medical-Oncology (ESMO), SEP 28-OCT 02, 2012, Vienna, AUSTRIA
Available from: 2013-01-03 Created: 2012-11-20 Last updated: 2013-01-03Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Ljungberg, Börje
By organisation
Urology and Andrology
In the same journal
Annals of Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 38 hits
ReferencesLink to record
Permanent link

Direct link